Загрузка...
Could imiquimod (Aldara 5% cream) or other TLR7 agonists be used in the treatment of COVID-19?
Toll-like receptor 7 is critical in recognition of single strand RNA viruses, including SARS CoV-2, and generation of anti-viral immunity. Coronaviruses evolved strategies to dampen the host immunity. Herein, we discuss the potential use of TLR7 agonists in the early stages of COVID-19 treatment.
Сохранить в:
| Опубликовано в: : | Med Hypotheses |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier Ltd.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434307/ https://ncbi.nlm.nih.gov/pubmed/33254510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.110202 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|